Status:
RECRUITING
Digitally Rendered Interventions And Knowledge To Limit Ethanol-Associated Atrial Fibrillation Severity
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Atrial Fibrillation (AF)
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Per the 2021 National Survey on Drug Use and Health administered by the U.S. Department of Health and Human Services, 85% of all American adults consume alcohol. Atrial fibrillation (AF) is the most c...
Detailed Description
This single center, randomized, controlled trial aims to compare the effects of a digital health intervention to encourage durable alcohol abstinence versus allowing guideline-adherent moderate alcoho...
Eligibility Criteria
Inclusion
- Are age 21 years or older
- Have a smartphone
- Are able to use the Eureka mobile application
- Have a history of paroxysmal or persistent atrial fibrillation (AF)
- Have consumed alcohol at least once per month on average in the past year
- Willing to receive messaging encouraging alcohol abstinence
Exclusion
- Non-english speaker
- Currently pregnant or trying to get pregnant
- A healthcare professional's instruction to avoid alcohol (for any reason)
- Currently incarcerated
- Permanent AF (meaning a medical determination has been made that sinus rhythm would definitely never be pursued in this patient)
- Are unable to read or sign to provide informed consent
Key Trial Info
Start Date :
April 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06995391
Start Date
April 20 2025
End Date
March 1 2030
Last Update
July 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF Medical Center at Parnassus
San Francisco, California, United States, 94143